Filing Details

Accession Number:
0001209191-19-010383
Form Type:
5
Zero Holdings:
No
Publication Time:
2019-02-14 18:07:00
Reporting Period:
2018-12-31
Accepted Time:
2019-02-14 18:07:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Nutrition Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472187 Edi Hienrich 800 W. Olympic Blvd. Suite 406
Los Angeles CA 90015
Svp/Managing Director Emea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-02 4,404 $30.44 2,780 No 4 M Indirect By wife
Common Stock Disposition 2018-03-02 2,919 $94.72 2,780 No 4 F Indirect By wife
Common Stock Disposition 2018-03-02 104 $91.77 2,780 No 4 S Indirect By wife
Common Stock Disposition 2018-03-02 183 $93.00 2,780 No 4 S Indirect By wife
Common Stock Disposition 2018-03-06 1,485 $95.57 2,780 No 4 S Indirect By wife
Common Stock Acquisiton 2018-05-09 655 $62.51 2,780 No 4 M Indirect By wife
Common Stock Disposition 2018-05-09 526 $111.17 2,780 No 4 F Indirect By wife
Common Stock Disposition 2018-05-11 129 $111.46 2,780 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By wife
No 4 F Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 F Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-03-02 4,404 $0.00 4,404 $30.44
Common Stock Stock Appreciation Rights Disposition 2018-05-09 655 $0.00 655 $62.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-03-02 2025-03-02 No 4 M Indirect
3,930 2026-05-09 No 4 M Indirect
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's wife.
  2. The Reporting Person's wife received 1,485 shares of common stock upon the net exercise of 4,404 stock appreciation rights ("SARS"). The Reporting Person's wife forfeited 1,416 shares of common stock underlying the SARS in payment of the exercise price and 1,503 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72. Since this transaction took place prior to the Issuer's 2-for-1 stock split on May 14, 2018, share numbers, market prices and exercise prices are provided without giving effect to the stock split.
  3. Balance reflects the amount of securities beneficially owned indirectly as of December 31, 2018, after giving effect to the Issuer's 2-for-1 stock split on May 14, 2018.
  4. Since this transaction took place prior to the Issuer's 2-for-1 stock split on May 14, 2018, share numbers and market price are provided without giving effect to the stock split.
  5. The Reporting Person's wife received 129 shares of common stock upon the net exercise of 655 SARS. The Reporting Person's wife forfeited 369 shares of common stock underlying the SARS in payment of the exercise price and 157 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on May 9, 2018 of $111.17. Since this transaction took place prior to the Issuer's 2-for-1 stock split on May 14, 2018, share numbers, market prices and exercise prices are provided without giving effect to the stock split.
  6. On May 9, 2016, the Reporting Person's wife was granted 3,275 SARS (prior to giving effect to the Issuer's 2-for-1 stock split on May 14, 2018). These SARS vested 20% each on May 9, 2017 and May 9, 2018, and the remaining 60% vests on May 9, 2019.
  7. Reflects share numbers after giving effect to the Issuer's 2-for-1 stock split on May 14, 2018.